These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 20514950)
1. A comparison of parametric and non-parametric approaches to target-controlled infusion of propofol. Crankshaw DP; Brown MJ; Bjorksten AR Anaesth Intensive Care; 2010 May; 38(3):437-44. PubMed ID: 20514950 [TBL] [Abstract][Full Text] [Related]
2. Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions. Coetzee JF Clin Pharmacokinet; 2012 Mar; 51(3):137-45. PubMed ID: 22316280 [TBL] [Abstract][Full Text] [Related]
3. Use of target controlled infusion to derive age and gender covariates for propofol clearance. White M; Kenny GN; Schraag S Clin Pharmacokinet; 2008; 47(2):119-27. PubMed ID: 18193918 [TBL] [Abstract][Full Text] [Related]
4. [Population pharmacokinetic modeling and evaluation of propofol from multiple centers]. Ye HB; Zheng H; Zhang XA; Chi XJ; Chen WY; Xu JG; Li JH; Rui JZ Yao Xue Xue Bao; 2010 Dec; 45(12):1550-8. PubMed ID: 21351496 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesia. Park JH; Choi SM; Park JH; Lee KH; Yun HJ; Lee EK; Choi BM; Noh GJ Br J Anaesth; 2018 Sep; 121(3):559-566. PubMed ID: 30115253 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children. Choi BM; Lee HG; Byon HJ; Lee SH; Lee EK; Kim HS; Noh GJ J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):163-77. PubMed ID: 25724290 [TBL] [Abstract][Full Text] [Related]
7. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data. Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of propofol: a multicenter study. Schüttler J; Ihmsen H Anesthesiology; 2000 Mar; 92(3):727-38. PubMed ID: 10719952 [TBL] [Abstract][Full Text] [Related]
9. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics. Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the performance of the Marsh model in effect site mode for target controlled infusion of propofol during the maintenance phase of general anaesthesia in an unselected population of neurosurgical patients. Cowley NJ; Hutton P; Clutton-Brock TH Eur J Anaesthesiol; 2013 Oct; 30(10):627-32. PubMed ID: 23962821 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail. Absalom AR; Mani V; De Smet T; Struys MM Br J Anaesth; 2009 Jul; 103(1):26-37. PubMed ID: 19520702 [TBL] [Abstract][Full Text] [Related]
12. [Accuracy of target-controlled infusion (TCI) with 2 different propofol formulations]. Ihmsen H; Jeleazcov C; Schüttler J; Schwilden H; Bremer F Anaesthesist; 2004 Oct; 53(10):937-43. PubMed ID: 15372176 [TBL] [Abstract][Full Text] [Related]
13. Influence of administration rate on propofol plasma-effect site equilibration. Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240 [TBL] [Abstract][Full Text] [Related]
14. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients. La Colla L; Albertin A; La Colla G; Ceriani V; Lodi T; Porta A; Aldegheri G; Mangano A; Khairallah I; Fermo I Eur J Anaesthesiol; 2009 May; 26(5):362-9. PubMed ID: 19307972 [TBL] [Abstract][Full Text] [Related]
15. Gender differences in the pharmacokinetics of propofol in elderly patients during and after continuous infusion. Vuyk J; Oostwouder CJ; Vletter AA; Burm AG; Bovill JG Br J Anaesth; 2001 Feb; 86(2):183-8. PubMed ID: 11573657 [TBL] [Abstract][Full Text] [Related]
16. Remifentanil concentration during target-controlled infusion of propofol. Crankshaw DP; Chan C; Leslie K; Bjorksten AR Anaesth Intensive Care; 2002 Oct; 30(5):578-83. PubMed ID: 12413255 [TBL] [Abstract][Full Text] [Related]
17. Performance of TCI Propofol Using the Schnider Model for Cardiac Surgery on Cardiopulmonary Bypass-A Pilot Study. Lee AKY; Kong AYH; Kong CF J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):723-730. PubMed ID: 29225156 [TBL] [Abstract][Full Text] [Related]
18. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate. Masui K; Kira M; Kazama T; Hagihira S; Mortier EP; Struys MM Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485 [TBL] [Abstract][Full Text] [Related]
19. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index. Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103 [TBL] [Abstract][Full Text] [Related]
20. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Cortínez LI; Anderson BJ; Penna A; Olivares L; Muñoz HR; Holford NH; Struys MM; Sepulveda P Br J Anaesth; 2010 Oct; 105(4):448-56. PubMed ID: 20710020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]